Long-term vitamin D supplementation demonstrates protective effect against relapse of Multiple Sclerosis: a systematic review
DOI:
https://doi.org/10.34024/rnc.2021.v29.10631Keywords:
Multiple sclerosis, Vitamin D, Nervous System, MyelinAbstract
Introduction. Multiple Sclerosis (MS) is a demyelinating, inflammatory, chronic and degenerative disease of the central nervous system. The main hypotheses for the disease is the genetic predisposition associated with environmental factors, which originates the immune system dysfunction. Studies suggest a relationship between vitamin D deficiency and MS, and according to researchers, vitamin D has a role in preventing and decreasing the rates of disease recurrence. Treatment for MS is established by the use of immunosuppressants and immunomodulators and some studies demonstrate evidence of the immunomodulary effects of vitamin D, which stimulates T cell activation in patients with MS. Objective. In the present study, we address the possibility to discuss and investigate, through a systematic review, the effectiveness of vitamin D supplementation treatment in MS patients. Method. This study is a systematic review of the literature, carried out in the electronic databases PubMed, MedLine, Scielo and Lilacs, using the combination of specific terms. Results. The scientific search resulted in 219 studies, however, applying the inclusion and exclusion criteria, five articles were selected. Conclusion. This review demonstrated that vitamin D supplementation, used for long periods, increases the amount of the metabolically active form of vitamin D in plasma, and consequently acts as a protective factor against MS. However, further studies are needed to elucidate the protective mechanism of vitamin D.
Metrics
References
Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36:S180-93.
https://doi.org/10.1002/ana.410360805
Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
https://doi.org/10.1146/annurev.immunol.23.021704.115707
Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology 2014;83:1022-4.
https://doi.org/10.1212/WNL.0000000000000768
Wade BJ. Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Multiple sclerosis international, Mult Scler Int 2014;2014:124578.
https://doi.org/10.1155/2014/124578
Evans E, Piccio L, Cross AH. Use of vitamins and dietary supplements by patients with multiple sclerosis: a review. JAMA Neurol 2018;75:1013-21. https://doi.org/10.1001/jamaneurol.2018.0611
Munger KL, Zhang SM, O’reilly E, Hernan MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5.
https://doi.org/10.1212/01.wnl.0000101723.79681.38
Callegaro D, Lana-Peixoto MA, Moreira MA, Marchiori PE, Bacheschi LA, Arruda WO, et al. Consenso expandido do bctrims para o tratamento da esclerose múltipla. Arq Neuropsiquiatr 2002;60:869-74. https://doi.org/10.1590/S0004-282X2002000500035
Mahan LK, Escott-Stump S. Krause, alimentos, nutrição & dietoterapia. São Paulo: Ed Roca, 2005, p.1256.
Román DDL, Guerrero DB, Luna PPG. Dietoterapia, nutrición clínica y metabolismo. Madrid: Ediciones Díaz de Santos. 2012, p.916.
Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheumat Dis 2007;66:1137-42. https://doi.org/10.1136/ard.2007.069831
Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003;134:128-32.
https://doi.org/10.1016/s0165-5728(02)00396-x
Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008;194:7-17. https://doi.org/10.1016/j.jneuroim.2007.11.014
Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, et al. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mul Scler J 2016;22:753-60.
https://doi.org/10.1177/1352458515600248
Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, et al. Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis. Neurology 2016;86:382-90. https://doi.org/10.1212/WNL.0000000000002316
Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Mult Scle Rel Dis 2016;10:169-73. https://doi.org/10.1016/j.msard.2016.10.005
Riccio P, Rossano R, Larocca M, Trotta V, Mennella I, Vitaglione P, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med 2016;241:620-35.
https://doi.org/10.1177/1535370215618462
Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J, et al. Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study. J Neuroimmunol 2016;300:47-56.
https://doi.org/10.1016/j.jneuroim.2016.09.018
Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, et al. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 2009;16:1176-86. https://doi.org/10.1128/CVI.00342-08
Moreira MA, Felipe E, Mendes MF, Tilbery CP. Esclerose múltipla: estudo descritivo de suas formas clínicas em 302 casos. Arq Neuropsiquiatr 2000;58:460-6. https://doi.org/10.1590/S0004-282X2000000300010
Maeda SS, Borba VZ, Camargo MBR, Silva DMW, Borges JLC, Bandeira F, et al. Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arq Bras Endocrinol Metabol 2014;58:411-33. https://doi.org/10.1590/0004-2730000003388
Bryant GA, Koenigsfeld CF, Lehman NP, Smith HL, Logemann CD, Phillips KT. A retrospective evaluation of response to vitamin D supplementation in obese versus nonobese patients. J Pharmac Pract 2015;28:543-7. https://doi.org/10.1177/0897190014544822
Singh G, Bonham AJ. A predictive equation to guide vitamin D replacement dose in patients. J Am Board Fam Med 2014;27:495-509. https://doi.org/10.3122/jabfm.2014.04.130306
Tepper S, Shahar DR, Geva D, Ish-Shalom S. Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000 IU vitamin D in healthy, men aged 25–65 years. J Steroid Biochemistr Mol Biol 2014;144:163-6.
https://doi.org/10.1016/j.jsbmb.2013.12.005
Anfossi N, Doisne JM, Peyrat MA, Ugolini S, Bonnaud O, Bossy D, et al. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. J Immunol 2004;173:7223-9. https://doi.org/10.4049/jimmunol.173.12.7223
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Fernanda Rodrigues Batista, Andrezza Fernanda Santiago, Everton Horiquini-Barbosa

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Accepted 2021-04-27
Published 2021-06-11
